Know Cancer

or
forgot password

Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer


Phase 3
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer


OBJECTIVES:

- Determine whether longitudinal and circumferential resection margins and lymphatic
clearances obtained during laparoscopic surgery are different from those obtained with
conventional open surgery in patients with colorectal cancer.

- Compare the patterns of loco-regional or distant metastatic spread after these two
surgical methods in these patients.

- Compare the morbidity and mortality rates in these patients after these two surgical
methods, particularly in terms of the technical or thromboembolic complications that
may develop as a consequence of prolonged pneumoperitoneum.

- Compare the disease-free or overall survival of these patients after these two
operative procedures.

- Determine, in those patients in whom laparoscopic surgery fails, which investigatory
modalities are appropriate for providing pre-operative indications that a patient is an
inappropriate candidate for laparoscopic dissection.

- Compare the differences in quality of life between the two operative procedures,
particularly in patients with advanced disease.

OUTLINE: This is a randomized, multicenter study.

Patients undergo laparoscopic surgery or conventional open surgery.

Patients are followed at 1 and 3 months following surgery, then every 3 months for the first
year, every 4 months for the second year, and then every 6 months thereafter.

PROJECTED ACCRUAL: Approximately 1,200 patients will be accrued for this study within 5
years.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Histologically confirmed colorectal cancer

- Must be suitable for elective surgical resection by right hemicolectomy, left
hemicolectomy, sigmoid colectomy, anterior resection or abdomino-perineal resection

- No adenocarcinoma of the transverse colon

- No synchronous multiple adenocarcinomas

PATIENT CHARACTERISTICS:

Age:

- 18 and over

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Not specified

Renal:

- Not specified

Pulmonary:

- No contraindication to pneumoperitoneum such as severe cardio-respiratory disease

Other:

- No acute intestinal obstruction

- No prior malignancy within the past 5 years, except basal cell carcinoma, carcinoma
in situ of the cervix, or prostate cancer

- Not pregnant

- No gastrointestinal disease that requires surgical intervention, e.g., Crohn's
disease, chronic ulcerative disease, familial polyposis

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- Not specified

Chemotherapy:

- Not specified

- Adjuvant chemotherapy allowed

Endocrine therapy:

- Not specified

Radiotherapy:

- Preoperative radiotherapy must be administered before randomization into this trial

- Adjuvant radiotherapy allowed

Surgery:

- See Disease Characteristics

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Primary Purpose: Treatment

Principal Investigator

P.J. Guillou, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Leeds Cancer Centre at St. James's University Hospital

Authority:

United States: Federal Government

Study ID:

CDR0000066336

NCT ID:

NCT00003354

Start Date:

July 1996

Completion Date:

Related Keywords:

  • Colorectal Cancer
  • stage I colon cancer
  • stage II colon cancer
  • stage III colon cancer
  • stage IV colon cancer
  • stage 0 colon cancer
  • stage 0 rectal cancer
  • stage I rectal cancer
  • stage II rectal cancer
  • stage III rectal cancer
  • stage IV rectal cancer
  • Colorectal Neoplasms

Name

Location